Research Directory

Case study - the merits of adaptive trial design

Read more

The next step for EU health technology assessment

Read more

When is one drug more effective than another?

Read more

Ipsen aspires to role as speciality oncology player

Read more

How Pharma is targeting checkpoint inhibitors

Read more

Progress towards personalised cancer vaccines

Read more

Update on the new EU Clinical Trials Regulation

Read more

New body for regenerative medicine launched

Read more

Seismic shift ahead for drug pricing

Read more

Drugs for orphan diseases are no longer rare

Read more